Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma

iScience - United States
doi 10.1016/j.isci.2019.06.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Anaplastic Lymphoma Kinase (ALK)

Science-Business eXchange
2008English

Targeting Anaplastic Lymphoma Kinase in Neuroblastoma

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
ImmunologyAllergyMicrobiologyMedicineForensic MedicinePathology
2019English

The Applications of Liquid Biopsy in Resistance Surveillance of Anaplastic Lymphoma Kinase Inhibitor

Cancer Management and Research
Oncology
2017English

Phosphoinositide 3-Kinase Inhibitors in Lymphoma

Current Opinion in Oncology
Cancer ResearchOncology
2014English

Development of Anaplastic Lymphoma Kinase (ALK) Inhibitors and Molecular Diagnosis in ALK Rearrangement-Positive Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2014English

Anaplastic Lymphoma Kinase (ALK) Inhibitors for Second-Line Therapy of Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2012English

A Recurrent Mutation in Anaplastic Lymphoma Kinase With Distinct Neoepitope Conformations

Frontiers in Immunology
AllergyImmunology
2018English

Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma

PLoS ONE
Multidisciplinary
2015English

The Effectiveness of Combined Medical Therapy and Hemodialysis for Hypercalcemia in Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma

The Showa University Journal of Medical Sciences
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy